Ensuring good nutritional status in patients with Parkinson's disease: challenges and solutions

References

• Mena I, Cotzias GC. Protein intake and treatment of Parkinson’s disease with levodopa. N Engl J Med. 1975;292(4):181–184.
   PubMed Web of Science ®Google Scholar
• Gasser T, Müller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson’s disease maps to chromosome 2p13. Nat Genet. 1998;18(3):262–265.
   PubMed Web of Science ®Google Scholar
• Jarman P, Wood N. Parkinson’s disease genetics comes of age. BMJ. 1999;318(7199):1641–1642.
   PubMedGoogle Scholar
• Lazzarini AM, Myers RH, Zimmerman TR Jr, et al. A clinical genetic study of Parkinson’s disease: evidence for dominant transmission. Neurology. 1994;44(3 Pt 1):499–506.
   PubMed Web of Science ®Google Scholar
• Scott WK, Nance MA, Watts RL, et al. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA. 2001;286(18):2239–2244.
   PubMed Web of Science ®Google Scholar
• Behari M, Srivastava AK, Das RR, Pandey RM. Risk factors of Parkinson’s disease in Indian patients. J Neurol Sci. 2001;190(1–2):49–55.
   PubMed Web of Science ®Google Scholar
• Ben-Shlomo Y. How far are we in understanding the cause of Parkinson’s disease? J Neurol Neurosurg Psychiatry. 1996;61(1):4–16.
   PubMed Web of Science ®Google Scholar
• Tanner CM, Goldman SM. Epidemiology of Parkinson’s disease. Neurol Clin. 1996;14(2):317–335.
   PubMed Web of Science ®Google Scholar
• Zuber M, Alperovitch A. [Parkinson’s disease and environmental factors]. Rev Epidemiol Sante Publique. 1991;39(4):373–387. French.
   PubMed Web of Science ®Google Scholar
• Tanner CM, Chen B, Wang WZ, et al. Environmental factors in the etiology of Parkinson’s disease. Can J Neurol Sci. 1987;14(Suppl 3):419–423.
   PubMed Web of Science ®Google Scholar
• Zhang ZX, Román GC. Worldwide occurrence of Parkinson’s disease: an updated review. Neuroepidemiology. 1993;12(4):195–208.
   PubMed Web of Science ®Google Scholar
• McCarty MF. Does vegan diet reduce risk of Parkinson’s disease? Med Hypotheses. 2001;57(3):318–323.
   PubMed Web of Science ®Google Scholar
• Beyer PL, Palarino MY, Michalek D, Busenbark K, Koller WC. Weight change and body composition in patients with Parkinson’s disease. J Am Diet Assoc. 1995;95(9):979–983.
   PubMedGoogle Scholar
• Cushing ML, Traviss KA, Calne SM. Parkinson’s disease: implications for nutritional care. Can J Diet Pract Res. 2002;63(2):81–87.
   PubMed Web of Science ®Google Scholar
• Tuite PJ, Maxwell RE, Ikramuddin S, et al. Weight and body mass index in Parkinson’s disease patients after deep brain stimulation surgery. Parkinsonism Relat Disord. 2005;11(4):247–252.
   PubMed Web of Science ®Google Scholar
• Uc EY, Struck LK, Rodnitzky RL, Zimmerman B, Dobson J, Evans WJ. Predictors of weight loss in Parkinson’s disease. Mov Disord. 2006; 21(7):930–936.
   PubMed Web of Science ®Google Scholar
• van der Marck MA, Dicke HC, Uc EY, et al. Body mass index in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord. 2012;18(3):263–267.
   PubMed Web of Science ®Google Scholar
• Sheard JM, Ash S, Silburn PA, Kerr GK. Prevalence of malnutrition in Parkinson’s disease: a systematic review. Nutr Rev. 2011;69(9): 520–532.
   PubMed Web of Science ®Google Scholar
• Barichella M, Villa MC, Massarotto A, et al. Mini Nutritional Assessment in patients with Parkinson’s disease: correlation between worsening of the malnutrition and increasing number of disease years. Nutr Neurosci. 2008;11(3):128–134.
   PubMed Web of Science ®Google Scholar
• Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK. Malnutrition in a sample of community-dwelling people with Parkinson’s disease. PLoS One. 2013;8(1):e53290.
   PubMed Web of Science ®Google Scholar
• Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK. Markers of disease severity are associated with malnutrition in Parkinson’s disease. PLoS One. 2013;8(3):e57986.
   PubMed Web of Science ®Google Scholar
• Arabia G, Zappia M, Bosco D, et al. Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson’s disease. Neurol Sci. 2002;23 Suppl 2:S53–S54.
   Google Scholar
• Bachmann CG, Zapf A, Brunner E, Trenkwalder C. Dopaminergic treatment is associated with decreased body weight in patients with Parkinson’s disease and dyskinesias. Eur J Neurol. 2009;16(8):895–901.
   PubMed Web of Science ®Google Scholar
• Sharma JC, Macnamara L, Hasoon M, Vassallo M, Ross I. Cascade of levodopa dose and weight-related dyskinesia in Parkinson’s disease (LD-WD-PD cascade). Parkinsonism Relat Disord. 2006;12(8):499–505.
   PubMed Web of Science ®Google Scholar
• Kumru H, Santamaria J, Valldeoriola F, Marti MJ, Tolosa E. Increase in body weight after pramipexole treatment in Parkinson’s disease. Mov Disord. 2006;21(11):1972–1974.
   PubMed Web of Science ®Google Scholar
• Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord. 2006;21(4):524–529.
   PubMed Web of Science ®Google Scholar
• Raja M, Bentivoglio AR. Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson’s Disease and other disorders. Curr Drug Saf. 2012;7(1):63–75.
   PubMedGoogle Scholar
• Barichella M, Marczewska AM, Mariani C, Landi A, Vairo A, Pezzoli G. Body weight gain rate in patients with Parkinson’s disease and deep brain stimulation. Mov Disord. 2003;18(11):1337–1340.
   PubMed Web of Science ®Google Scholar
• Gironell A, Pascual-Sedano B, Otermin P, Kulisevsky J. [Weight gain after functional surgery for Parkinsons disease]. Neurologia. 2002; 17(6):310–316. Spanish.
   PubMed Web of Science ®Google Scholar
• Perlemoine C, Macia F, Tison F, et al. Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson’s disease. Br J Nutr. 2005;93(2):191–198.
   PubMed Web of Science ®Google Scholar
• Macia F, Perlemoine C, Coman I, et al. Parkinson’s disease patients with bilateral subthalamic deep brain stimulation gain weight. Mov Disord. 2004;19(2):206–212.
   PubMed Web of Science ®Google Scholar
• Kistner A, Lhommée E, Krack P. Mechanisms of body weight fluctuations in Parkinson’s disease. Front Neurol. 2014;5:84.
   PubMed Web of Science ®Google Scholar
• Deleu D, Northway MG, Hanssens Y. Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson’s disease. Clin Pharmacokinet. 2002;41:261–309.
   PubMed Web of Science ®Google Scholar
• Kempster PA, Wahlqvist ML. Dietary factors in the management of Parkinson’s disease. Nutr Rev. 1994;52(2 Pt 1):51–58.
   PubMed Web of Science ®Google Scholar
• Schwartz SE, Levine RA, Singh A, Scheidecker JR, Track NS. Sustained pectin ingestion delays gastric emptying. Gastroenterology. 1982;83(4): 812–817.
   PubMed Web of Science ®Google Scholar
• Astarloa R, Mena MA, Sánchez V, de la Vega L, de Yébenes JG. Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease. Clin Neuropharmacol. 1992;15(5):375–380.
   PubMed Web of Science ®Google Scholar
• Khor SP, Hsu A. The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson’s disease. Curr Clin Pharmacol. 2007;2(3):234–243.
   PubMedGoogle Scholar
• Nutt JG, Fellman JH. Pharmacokinetics of levodopa. Clin Neuropharmacol. 1984;7(1):35–49.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem. 1977;28(1): 103–108.
   PubMed Web of Science ®Google Scholar
• Leenders KL, Poewe WH, Palmer AJ, Brenton DP, Frackowiak RS. Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography. Ann Neurol. 1986;20(2):258–262.
   PubMed Web of Science ®Google Scholar
• Nutt JG, Woodward WR, Carter JH, Trotman TL. Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa. J Neurol Neurosurg Psychiatry. 1989;52(4):481–487.
   PubMed Web of Science ®Google Scholar
• Nutt JG, Carter JH, Lea ES, Woodward WR. Motor fluctuations during continuous levodopa infusions in patients with Parkinson’s disease. Mov Disord. 1997;12(3):285–292.
   PubMed Web of Science ®Google Scholar
• Pincus JH, Barry KM. Dietary method for reducing fluctuations in Parkinson’s disease. Yale J Biol Med. 1987;60(2):133–137.
   PubMed Web of Science ®Google Scholar
• Pincus JH, Barry K. Influence of dietary protein on motor fluctuations in Parkinson’s disease. Arch Neurol. 1987;44(3):270–272.
   PubMedGoogle Scholar
• Pincus JH, Barry KM. Plasma levels of amino acids correlate with motor fluctuations in parkinsonism. Arch Neurol. 1987;44(10):1006–1009.
   PubMedGoogle Scholar
• Eriksson T, Granérus AK, Linde A, Carlsson A. ‘On-off’ phenomenon in Parkinson’s disease: relationship between dopa and other large neutral amino acids in plasma. Neurology. 1988;38(8):1245–1248.
   PubMed Web of Science ®Google Scholar
• Tsui JK, Ross S, Poulin K, et al. The effect of dietary protein on the efficacy of L-dopa: a double-blind study. Neurology. 1989;39(4):549–552.
   PubMed Web of Science ®Google Scholar
• Wajsbort J. [The “off-on” phenomenon during treatment of parkinson’s disease with levodopa (author’s transl)]. J Neurol. 1977;215(1):59–66. German.
   PubMed Web of Science ®Google Scholar
• Marczewska A, De Notaris R, Sieri S, Barichella M, Fusconi E, Pezzoli G. Protein intake in Parkinsonian patients using the EPIC food frequency questionnaire. Mov Disord. 2006;21(8):1229–1231.
   PubMed Web of Science ®Google Scholar
• Berry EM, Growdon JH, Wurtman JJ, Caballero B, Wurtman RJ. A balanced carbohydrate: protein diet in the management of Parkinson’s disease. Neurology. 1991;41(8):1295–1297.
   PubMed Web of Science ®Google Scholar
• Bracco F, Malesani R, Saladini M, Battistin L. Protein redistribution diet and antiparkinsonian response to levodopa. Eur Neurol. 1991;31(2): 68–71.
   PubMed Web of Science ®Google Scholar
• Carter JH, Nutt JG, Woodward WR, Hatcher LF, Trotman TL. Amount and distribution of dietary protein affects clinical response to levodopa in Parkinson’s disease. Neurology. 1989;39(4):552–556.
   PubMed Web of Science ®Google Scholar
• Pincus JH, Barry K. Protein redistribution diet restores motor function in patients with dopa-resistant “off” periods. Neurology. 1988;38(3): 481–483.
   PubMed Web of Science ®Google Scholar
• Giménez-Roldán S, Mateo D. Predicting beneficial response to a protein-redistribution diet in fluctuating Parkinson’s disease. Acta Neurol Belg. 1991;91(4):189–200.
   PubMed Web of Science ®Google Scholar
• Karstaedt PJ, Pincus JH. Protein redistribution diet remains effective in patients with fluctuating parkinsonism. Arch Neurol. 1992;49(2): 149–151.
   PubMedGoogle Scholar
• Giménez-Roldán S, Mateo D, García Almansa A, García Peris P. [Proposal for a protein redistribution diet in the control of motor fluctuations in Parkinson’s disease: acceptance and efficacy]. Neurologia. 1991;6(1):3–9. Spanish.
   PubMedGoogle Scholar
• Cereda E, Barichella M, Pedrolli C, Pezzoli G. Low-protein and protein-redistribution diets for Parkinson’s disease patients with motor fluctuations: a systematic review. Mov Disord. 2010;25(13): 2021–2034.
   PubMed Web of Science ®Google Scholar
• Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson’s disease: treatment guidelines. American Academy of Neurology. Neurology. 1998;50(3 Suppl 3):S1–S57.
   PubMed Web of Science ®Google Scholar
• Riley D, Lang AE. Practical application of a low-protein diet for Parkinson’s disease. Neurology. 1988;38(7):1026–1031.
   PubMed Web of Science ®Google Scholar
• Nielsen SS, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Nicotine from edible Solanacee and risk of Parkinson disease. Ann Neurol. 2013;74(3):472–477.
   PubMed Web of Science ®Google Scholar
• Seidl SE, Santiago JA, Bilyk H, Potashkin JA. The emerging role of nutrition in Parkinson’s disease. Front Aging Neurosci. 2014;6:36.
   PubMed Web of Science ®Google Scholar
• Shaltiel-Karyo R, Frenkel-Pinter M, Rockenstein E, et al. A boodbrain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD). J Biol Chem. 2013;288(24):17579–17588.
   PubMed Web of Science ®Google Scholar
• Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov. 2004;3(3):205–214.
   PubMed Web of Science ®Google Scholar
• Maguire-Zeiss KA, Short DW, Federoff HJ. Synuclein, dopamine and oxidative stress: co-cospirators in Parkinson’s disease? Brain Res Mol Brain Res. 2005;134(1):18–23.
   PubMedGoogle Scholar
• Scheider WL, Hershey LA, Vena JE, Holmlund T, Marshall JR, Freudenheim. Dietary antioxidants and other dietary factors in the etiology of Parkinson’s disease. Mov Disord. 1997;12(2):190–196.
   PubMed Web of Science ®Google Scholar
• de Rijk MC, Breteler MM, den Breeijen JH, et al. Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch Neurol. 1997;54(6): 762–765.
   PubMedGoogle Scholar
• Etminan M, Gill SS, Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson’s disease: a meta-analysis. Lancet Neurol. 2005;4(6):362–365.
   PubMed Web of Science ®Google Scholar
• Miyake Y, Fukushima W, Tanaka K, et al. Dietary intake of antioxidant vitamins and risk of Parkinson’s disease: a case-control study in Japan. Eur J Neurol. 2011;18(1):106–113.
   PubMed Web of Science ®Google Scholar
• Zhang SM, Hernán MA, Chen H, Spiegelman D, Willett WC, Ascherio A. Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology. 2002;59(8):1161–1169.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu L, Barger SW, Mrak RE, Griffin WS. Vitamin E suppression of microglial activation is neuroprotective. J Neurosci Res. 2001;66(2): 163–170.
   PubMed Web of Science ®Google Scholar
• Grunewald RA. Ascorbic acid in the brain. Brain Res Brain Res Rev. 1993;18(1):123–133.
   PubMedGoogle Scholar
• Fahn S. A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson’s disease. Ann Neurol. 1992;32 Suppl:S128–S132.
   Web of Science ®Google Scholar
• Jiménez-Jiménez FJ, Molina JA, Fernández-Calle P, et al. Serum levels of beta-carotene and other carotenoids in Parkinson’s disease. Neurosci Lett. 1993;157(1):103–106.
   PubMed Web of Science ®Google Scholar
• Upchurch GR Jr, Welch GN, Fabian AJ, et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem. 1997;272(27):17012–17017.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang SM, Schwarzschild MA, et al. Folate intake and risk of Parkinson’s disease. Am J Epidemiol. 2004;160(4):368–375.
   PubMed Web of Science ®Google Scholar
• de Lau LM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology. 2006;67(2):315–318.
   PubMed Web of Science ®Google Scholar
• Murakami K, Miyake Y, Sasaki S, et al. Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson’s disease: a case-control study in Japan. Br J Nutr. 2010;104(5):757–764.
   PubMed Web of Science ®Google Scholar
• Ding H, Dhima K, Lockhart KC, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 2013;81(17):1531–1537.
   PubMed Web of Science ®Google Scholar
• Peterson AL. A review of vitamin D and Parkinson’s disease. Maturitas. 2014;78(1):40–44.
   PubMed Web of Science ®Google Scholar
• Ngim CH, Devathasan G. Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson’s disease. Neuroepidemiology. 1989;8(3):128–141.
   PubMed Web of Science ®Google Scholar
• Johnson CC, Gorell JM, Rybicki BA, Sanders K, Peterson EL. Adult nutrient intake as a risk factor for Parkinson’s disease. Int J Epidemiol. 1999;28(6):1102–1109.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Marder K, Graziano J, et al. Dietary iron, animal fats, and risk of Parkinson’s disease. Mov. Disord. 1998;13 Suppl 1:13–16.
   Google Scholar
• Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H. Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology. 2003;60(11): 1761–1766.
   PubMed Web of Science ®Google Scholar
• Schipper HM. Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol. 2000;35(6–7):821–830.
   PubMed Web of Science ®Google Scholar
• Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD. Dietary factors in Parkinson’s disease: the role of food groups and specific foods. Mov Disord. 1999;14(1):21–27.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Marder K, Cote L, Tang MX, Shea S, Mayeux R. Dietary lipids and antioxidants in Parkinson’s disease: a population-based, case-control study. Ann Neurol. 1996;39(1):89–94.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A. Dietary intake of fat and risk of Parkinson’s disease. Am J Epidemiol. 2003;157(11):1007–1014.
   PubMed Web of Science ®Google Scholar
• Hellenbrand W, Boeing H, Robra BP, et al. Diet and Parkinson’s disease. II: a possible role for the past intake of specific nutrients. Result from a self-administered food-frequency questionnaire in a case-control study. Neurology. 1996;47(3):644–650.
   PubMed Web of Science ®Google Scholar
• Peers R. Fatty diet, mitochondria and Parkinson’s disease. N Z Med J. 1997;110(1041):132.
   PubMed Web of Science ®Google Scholar
• de Lau LM, Bornebroek M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology. 2005;64(12):2040–2045.
   PubMed Web of Science ®Google Scholar
• Kamel F, Goldman SM, Umbach DM, et al. Dietary fat intake, pesticide use, and Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(1):82–87.
   PubMed Web of Science ®Google Scholar
• Morens DM, Grandinetti A, Waslien CI, Park CB, Ross GW, White LR. Case-control study of idiopathic Parkinson’s disease and dietary vitamin E intake. Neurology. 1996;46(5):1270–1274.
   PubMed Web of Science ®Google Scholar
• Ghosh A, Saminathan H, Kanthasamy A, et al. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease. J Biol Chem. 2013;288(30):21955–21971.
   PubMed Web of Science ®Google Scholar
• Ryo A, Togo T, Nakai T, et al. Prolyl-isomerase Pin1 accumulates in lewy bodies of Parkinson disease and facilitates formation of alpha-synuclein inclusions. J Biol Chem. 2006;281:4117–4125.
   PubMed Web of Science ®Google Scholar
• Chen H, O’Reilly E, McCullough ML, et al. Consumption of dairy products and risk of Parkinson’s disease. Am J Epidemiol. 2007;165(9): 998–1006.
   PubMed Web of Science ®Google Scholar
• Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece. Eur J Epidemiol. 2013;28(1):67–77.
   PubMed Web of Science ®Google Scholar
• Park M, Ross GW, Petrovitch H, et al. Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology. 2005;64(6):1047–1051.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang SM, Hernán MA, Willett WC, Ascherio A. Diet and Parkinson’s disease: a potential role of dairy products in men. Ann Neurol. 2002;52(6):793–801.
   PubMed Web of Science ®Google Scholar
• Behrooz RD, Sahebi S, Majnoni F, Ahmadpour M, Hoseini SH. Mercury contamination in commercial fresh and salt water fish of the Zabol Chahnimeh reservoirs and the Gulf of Oman (Iran). Food Addit Contam Part B Surveill. 2013;6(3):175–180.
   PubMed Web of Science ®Google Scholar
• Bravo AG, Cosio C, Amouroux D, et al. Extremely elevated methyl mercury levels in water, sediment and organisms in a Romanian reservoir affected by release of mercury from a chlor-alkali plant. Water Res. 2014;49:391–405.
   PubMed Web of Science ®Google Scholar
• Chételat J, Amyot M, Arp P, et al. Mercury in freshwater ecosystems of the Canadian Arctic: Recent advances on its cycling and fate. Sci Total Environ. Epub June 30, 2014.
   Google Scholar
• Johnsson C, Schütz A, Sällsten G. Impact of consumption of freshwater fish on mercury levels in hair, blood, urine, and alveolar air. J Toxicol Environ Health A. 2005;68(2):129–140.
   PubMed Web of Science ®Google Scholar
• Sources of mercury pollution and the methylmercury contamination of fish in Minnesota [webpage on the Internet]. Minnesota: Minnesota Pollution Control Agency (MPCA); 2013. Available from: http://www.pca.state.mn.us/index.php/view-document.html?gid=288. Accessed October 25, 2014.
   Google Scholar
• National Study of Chemical Residues in Lake Fish Tissue [webpage on the Internet]. Washington (DC): United States Environmental Protection Agency; 2009. Available from: http://water.epa.gov/scitech/swguidance/fishstudies/results.cfm#results1. Accessed October 25, 2014.
   Google Scholar
• Ascherio A, Zhang SM, Hernán MA, et al. Prospective study of caffeine consumption and risk of Parkinson’s disease in men and women. Ann Neurol. 2001;50(1):56–63.
   PubMed Web of Science ®Google Scholar
• Costa J, Lunet N, Santos C, Santos J, Vaz-Corneiro A. Caffeine exposure and the risk of Parkinson’s disease: a systematic review and meta-analyis of observational studies. J Alzheimers Dis. 2010;20 Suppl 1:S221–S238.
   Google Scholar
• Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J. Coffee and tea consumption and the risk of Parkinson’s disease. Mov Disord. 2007;22(15):2242–2248.
   PubMed Web of Science ®Google Scholar
• Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000;283(20):2674–2679.
   PubMed Web of Science ®Google Scholar
• Sääksjärvi K, Knekt P, Rissanen H, Laaksonen MA, Reunanen A, Männistö S. Prospective study of coffee consumption and risk of Parkinson’s disease. Eur J Clin Nutr. 2008;62(7):908–915.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Chen H, Schwarzschild MA, Zhang SM, Colditz GA, Speizer FE. Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease. Neurology. 2003;60(5):790–795.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Weisskopf MG, O’Reilly EJ, et al. Coffee consumption, gender, and Parkinson’s disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol. 2004;160(10):977–984.
   PubMed Web of Science ®Google Scholar
• Liu R, Guo X, Park Y, et al. Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol. 2012;175(11): 1200–1207.
   PubMed Web of Science ®Google Scholar
• Li FJ, Ji HF, Shen L. A meta-analysis of tea drinking and risk of Parkinson’s disease. ScientificWorldJournal. 2012;2012:923464.
   PubMedGoogle Scholar
• Pan T, Jankovic J, Le W. Potential therapeutic properties of green tea polyphenols in Parkinson’s disease. Drugs Aging. 2003;20(10): 711–721.
   PubMed Web of Science ®Google Scholar
• Mandel SA, Amit T, Weinreb O, Youdim MB. Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases. J Alzheimers Dis. 2011;25(2): 187–208.
   PubMed Web of Science ®Google Scholar
• Mandel SA, Weinreb O, Amit T, Youdim MB. Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols. Front Biosci (Schol Ed). 2012;4:581–598.
   PubMedGoogle Scholar
• Muangpaisan W, Mathews A, Hori H, Seidel D. A systematic review of the worldwide prevalence and incidence of Parkinson’s disease. J Med Assoc Thai. 2011;94(6):749–755.
   PubMedGoogle Scholar
• Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer’s disease. Ann Neurol. 2006;59(6):912–921.
   PubMed Web of Science ®Google Scholar
• Alcalay RN, Gu Y, Mejia-Santana H, Cote L, Marder KS, Scarmeas N. The association between Mediterranean diet adherence and Parkinson’s disease. Mov Disord. 2012;27(6):771–774.
   PubMed Web of Science ®Google Scholar
• Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007;86(5):1486–1494.
   PubMed Web of Science ®Google Scholar
• Okubo H, Miyake Y, Sasaki S, et al. Dietary patterns and risk of Parkinson’s disease: a case-control study in Japan. Eur J Neurol. 2012;19(5):681–688.
   PubMed Web of Science ®Google Scholar
• Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008;337:a1344.
   PubMed Web of Science ®Google Scholar
• Lopez-Garcia E, Schulze MB, Fung TT. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2004;80(4):1029–1035.
   PubMed Web of Science ®Google Scholar
• Fung TT, McCullough ML, Newby PK, et al. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2005;82(1):163–173.
   PubMed Web of Science ®Google Scholar
• McGeer PL, McGeer EG. Inflammation and neurodegeneration in Parkinson’s disease. Parkinsonism Relat Disord. 2004;10 Suppl 1: S3–S7.
   Google Scholar
• Collier DS, Berg MJ, Fincham RW. Parkinsonism treatment: Part III – Update. Ann Pharmacother. 1992;26(2):227–233.
   PubMed Web of Science ®Google Scholar
• Evatt ML. Nutritional therapies in Parkinson’s disease. Curr Treat Options Neurol. 2007;9(3):198–204.
   PubMedGoogle Scholar
• Håglin L, Selander B. [Diet in Parkinson disease]. Tidsskr Nor Laegeforen. 2000;120(5):576–578. Norwegian.
   PubMedGoogle Scholar
• Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson’s disease. Mov Disord. 2009;24(13): 1881–1892.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. Food and Nutrition Board, National Academies. Dietary Reference Intakes (DRIs). Washington (DC): National Academies Press; 2011. Available from: http://www.iom.edu/Activities/Nutrition/SummaryDRIs/~/media/Files/Activity%20Files/Nutrition/DRIs/5_Summary%20Table%20Tables%201-4.pdf. Accessed August 22, 2014.
   Google Scholar
• Andrès E, Loukili NH, Noel E, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ. 2004;171(3):251–259.
   PubMed Web of Science ®Google Scholar
• Kumar N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol. 2014;120:915–926.
   PubMedGoogle Scholar
• Lachner C, Steinle NI, Regenold WT. The neuropsychiatry of vitamin B12 deficiency in elderly patients. J Neuropsychiatry Clin Neurosci. 2012;24(1):5–15.
   PubMed Web of Science ®Google Scholar
• Allen LH. How common is vitamin B-12 deficiency? Am J Clin Nutr. 2009;89(2):693S–696S.
   PubMed Web of Science ®Google Scholar
• Mahajan R, Gupta K. Revisiting metformin: annual vitamin B12 supplementation may become mandatory with long-term metformin use. J Young Pharm. 2010;2(4):428–429.
   PubMedGoogle Scholar
• Wilhelm SM, Rjater RG, Kale-Pradhan PB. Perils and pitfalls of long-term effects of proton pump inhibitors. Expert Rev Clin Pharmacol. 2013;6(4):443–451.
   PubMed Web of Science ®Google Scholar
• USDA. Dietary Guidelines for Americans 2010. US Department of Agricolture and Department of Health and Human Services. Available from: http://www.cnpp.usda.gov/sites/default/files/dietary_guidelines_for_americans/PolicyDoc.pdf. Accessed November 23, 2014.
   Google Scholar
• Messina V, Melina V, Mangels AR. A new food guide for North American vegetarians. J Am Diet Assoc. 2003;103(6):771–775.
   PubMedGoogle Scholar
• Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross AC, Taylor CL, Yaktine AL, et al, editors. Washington (DC): National Academies Press (US); 2011.
   Google Scholar
• Appleby P, Roddam A, Allen N, Key T. Comparative fracture risk in vegetarians and nonvegetarians in EPIC-Oxford. Eur J Clin Nutr. 2007;61(12):1400–1406.
   PubMed Web of Science ®Google Scholar
• Chiu JF, Lan SJ, Yang CY, et al. Long-term vegetarian diet and bone mineral density in postmenopausal Taiwanese women. Calcif Tissue Int. 1997;60(3):245–249.
   PubMed Web of Science ®Google Scholar
• Reed JA, Anderson JJ, Tylavsky FA, Gallagher PN Jr. Comparative changes in radial-bone density of elderly female lacto-ovovegetarians and omnivores. Am J Clin Nutr. 1994;59(5 Suppl):1197S–1202S.
   PubMed Web of Science ®Google Scholar
• Craig WJ, Mangels AR; American Dietetic Association. Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc. 2009;109(7):1266–1282.
   PubMedGoogle Scholar
• Heaney RP, Dowell MS, Rafferty K, Bierman J. Bioavailability of the calcium in fortified soy imitation milk, with some observations on method. Am J Clin Nutr. 2000;71(5):1166–1169.
   PubMed Web of Science ®Google Scholar
• Heaney RP. Absorbability and utility of calcium in mineral waters. Am J Clin Nutr. 2006;84(2):371–374.
   PubMed Web of Science ®Google Scholar
• Van der Velde RY, Brouwers RB, Geusens PB, Lems WF, van den Bergh JP. Calcium and vitamin D supplementation: state of the art for daily practice. Food Nutr Res. 2014;58. Available from: http://dx.doi.org/10.3402/fnr.v58.21796. Accessed August 19, 2014.
   Google Scholar
• Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, et al. Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int. 2013;24(5): 1567–1577.
   PubMed Web of Science ®Google Scholar
• Aloia JF. Clinical Review: The 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin Endocrinol Metab. 2011;96(10):2987–2996.
   Google Scholar
• Salonen JT, Seppänen K, Nyyssönen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91(3):645–655.
   PubMed Web of Science ®Google Scholar
• EFSA. Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal. 2010;8(3):1461[107 pp]. Available from: http://www.efsa.europa.eu/it/efsajournal/pub/1461.htm Accessed August 22, 2014.
   Google Scholar
• Ryan L, Symington AM. Algal-oil supplements are a viable alternative to fish-oil supplements in terms of docosahexaenoic acid (22:6n-3; DHA). J Funct Foods. 2014. DOI: 10.1016/j.jff.2014.06.023.
   Web of Science ®Google Scholar
• USDA National Nutrient Database for Standard Reference [homepage on the Internet]. USDA; 2011. Available from: http://ndb.nal.usda.gov. Accessed August 16, 2014.
   Google Scholar
• Messina V, Mangels R, Messina M. The Dietitian’s Guide to Vegetarian Diets: Issues and Applications. 3rd ed. Sudbury, MA: Jones and Bartlett Publishers; 2011.
   Google Scholar
• Barichella M, Marczewska A, De Notaris R, et al. Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson’s disease. Mov Disord. 2006;21(10):1682–1687.
   PubMed Web of Science ®Google Scholar
• Vilming ST. [Diet therapy in Parkinson disease] Tidsskr Nor Laegeforen. 1995;115(10):1244–1247. Norwegian.
   PubMedGoogle Scholar
• Pare S, Barr SI, Ross SE. Effect of daytime protein restriction on nutrient intakes of free-living Parkinson’s disease patients. Am J Clin Nutr. 1992;55(3):701–707.
   PubMed Web of Science ®Google Scholar
• Crowe FL, Appleby PN, Allen NE, Key TJ. Diet and risk of diverticular disease in Oxford cohort of European Prospective Investigation into Cancer and Nutrition (EPIC): prospective study of British vegetarians and non-vegetarians. BMJ. 2011;343:d4131.
   PubMed Web of Science ®Google Scholar
• Key TJ, Davey GK, Appleby PN. Health benefits of a vegetarian diet. Proc Nutr Soc. 1999;58(2):271–275.
   PubMed Web of Science ®Google Scholar
• Senard JM, Brefel-Courbon C, Rascol O, Montastruc JL. Orthostatic hypotension in patients with Parkinson’s disease: pathophysiology and management. Drugs Aging. 2001;18(7):495–505.
   PubMed Web of Science ®Google Scholar
• Rogers JD, Sanchez-Saffon A, Frol AB, Diaz-Arrastia R. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. Arch. Neurol. 2003;60(1):59–64.
   PubMedGoogle Scholar
• Baroni L, Bonetto C, Tessan F, et al. Pilot dietary study with normoproteic protein-redistributed plant-food diet and motor performance in patients with Parkinson’s disease. Nutr Neurosci. 2011;14(1): 1–9.
   PubMed Web of Science ®Google Scholar
• Italian Research Institute for Food and Nutrition (INRAN). Tables of Food Composition. Update 2000, Carnovale and Marlettaeds, Milan (Italy): EDRA srlpublisher; © INRAN 2000.
   Google Scholar
• Barnard ND, Gloede L, Cohen J, et al. A low-fat vegan diet elicits greater macronutrient changes, but is comparable in adherence and acceptability, compared with a more conventional diabetes diet among individuals with type 2 diabetes. J Am Diet Assoc. 2009;109(2): 263–272.
   PubMed Web of Science ®Google Scholar
• Barnard ND, Katcher HI, Jenkins DJ, Cohen J, Turner-McGrievy G. Vegetarian and vegan diets in type 2 diabetes management. Nutr Rev. 2009;67(5):255–263.
   PubMed Web of Science ®Google Scholar
• Paul L. Diet, nutrition and telomere length. J Nutr Biochem. 2011; 22(10):895–901.
   PubMed Web of Science ®Google Scholar
• Ornish D, Lin J, Chan JM, et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013;14(11):1112–1120.
   PubMed Web of Science ®Google Scholar